Jay Reinstein and Michele Hall wouldn’t seem to most people like they would be in danger of suffering from a disease typically associated with aging.
Reinstein is just 60 years old, and Hall is 54. Both of them have young adult children. Yet both already struggle with driving, and they can no longer work because their minds don’t function as they once did.
They’re two of the 200,000 Americans who suffer from early-onset Azheimer’s disease, a group of people who received crushing news Tuesday when Medicare proposed limiting their access to a potential treatment called Aduhelm meant to slow…
